: iStockAnalyst.com Symbols Feed

The Deep, Inner Meaning Of Bank of America's (BAC) TARP Repayment

Fri, 04 Dec 2009 14:19:07 GMT

As expected, Bank of America (BAC) will repurchase its $45 billion TARP preferreds, funded in part by an additional $18.8 billion in "common stock equivalents", $4.0 billion in asset sales, and $1.7 billion in restricted stock issued to employees in lieu of cash bonuses.[More...]

Forget Yesterday, It's All About Jobs

Fri, 04 Dec 2009 13:21:30 GMT

Good morning. Stocks tanked in the last half-hour on Thursday and while the major news outlets attributed the decline to either profit taking or some trepidation in front of this morning's big Jobs report, we'd like to offer a little more substantial reason for the 85 point dive on an otherwise subdued day of trading.[More...]

Fed Balance Sheet Declines By $15 Billion After Improbable Reduction In MBS, Excess Reserves, Monetary Base Hit Record

Fri, 04 Dec 2009 04:14:41 GMT

The Federal Reserve's balance sheet declined by $15 billion to $2,183 billion from the prior week, after the Fed presumably offloaded $2.7 billion in MBS: this is the first time since QE started that MBS holdings have declined. If anyone can tell us just who the idiots are who bought MBS from the Fed (and at what price), and who the even greater idiots are who are supposed to believe this, please send us an email.[More...]

China Will Continue To Drive The Global Economic Recovery In 2010

Thu, 03 Dec 2009 14:38:07 GMT

China isn’t just leading the global economic recovery – it’s lapping the field.[More...]

Interesting Stat: How Much Private Sector GDP Is From Construction And Real Estate?

Thu, 03 Dec 2009 13:15:56 GMT

Back in June, we discussed commercial real estate at length following attendance at a large real estate conference in NYC. Our tone was cautious and one question we wondered about was the percentage of GDP that real estate represents. We actually came across the answer back in August and meant to share then, but didn't get to it. Since the question/topic remains highly relevant to considering the potential negative economic drag from depressed real estate activity, we're sharing now -- the following table is from an 8/28/09 NYTs article, "Construction That Fueled Growth in the Sun Belt Slows":[More...]

Credit Market Overview: Dec 3, 2009

Thu, 03 Dec 2009 12:59:02 GMT

The credit crunch crisis of confidence which we appear to be crawling out of even though the debt and equity markets catapulted themselves higher earlier this year could be similarly argued to be a crisis that started in the credit markets which crunched confidence around the world as it could a collapse in confidence in the value of the securities investors held which corrupted the credit markets causing them to cease funding.[More...]

Grab Some Northern Exposure With EWC

Wed, 02 Dec 2009 21:39:42 GMT

Emerging markets are captivating investors again, but tidy profits aren’t always far away. Placing your bets on well-established global markets can also prove rewarding. That's why we're looking at Canada.[More...]

Unemployment Struggling To Turn A Corner As Job Losses Mount In November

Wed, 02 Dec 2009 21:20:20 GMT

U.S. job losses in the private sector slowed in November but still exceeded economists’ projections, a report by payroll-processing firm Automatic Data Processing (Nasdaq: ADP) indicated yesterday (Wednesday).[More...]

Why Barrick Closed Their Gold Hedge

Wed, 02 Dec 2009 19:15:14 GMT

It sure looks like gold is going to close above $1,200 an ounce today in New York. And large open market purchases from central banks in China, India and Russia are only helping the price surge more. (Just one year ago, some of these same central banks were actually selling gold in an attempt to fill an annual 10,000-ton supply gap.)[More...]

ImmunoCellular (OTC: IMUC.OB) Notches Deal For New Cancer Stem Cell Vaccine Target

Wed, 02 Dec 2009 15:04:42 GMT

In an option agreement announced today with MD Anderson Medical Center, ImmunoCellular Therapeutics (OTC: IMUC.OB) has acquired the rights to novel peptides that elicit a T-cell immune response against validated cancer stem cell targets known as the Notch and Numb pathways.[More...]

Evening Standard, London, market report column

Thu, 03 Dec 2009 18:48:00 GMT

Dec. 3--Commodity stocks should keep rising next year, but the best is behind the financials.
That's the opinion of Goldman Sachs, whose strategy suggestions for 2010 were being circulated in the City today.
Shares in London rose, with the FTSE putting on 30.71 points to 5358.10 as the banks bounced back from yesterday's losses.

: iStockAnalyst.com Symbols Feed

The Deep, Inner Meaning Of Bank of America's (BAC) TARP Repayment

Forget Yesterday, It's All About Jobs

Fed Balance Sheet Declines By $15 Billion After Improbable Reduction In MBS, Excess Reserves, Monetary Base Hit Record

China Will Continue To Drive The Global Economic Recovery In 2010

Interesting Stat: How Much Private Sector GDP Is From Construction And Real Estate?

Credit Market Overview: Dec 3, 2009

Grab Some Northern Exposure With EWC

Unemployment Struggling To Turn A Corner As Job Losses Mount In November

Why Barrick Closed Their Gold Hedge

ImmunoCellular (OTC: IMUC.OB) Notches Deal For New Cancer Stem Cell Vaccine Target

Evening Standard, London, market report column

Poniard raises $7.4 million in equity financing

Seasonal flu vaccine supplies spur worries

FDA approves additional H1N1 vaccine

Daily Mail, London, market report column

Drug industry presses FDA to allow more online ads

Targacept has profit in quarter: Large milestone payment by AstraZeneca credited for first profit in almost three years

Auditor: Canada disaster planning is poor

Vaccine-short Canada exporting 'surplus'

Largest malaria vaccine trial under way

Agennix AG Reports Financial Results for Third Quarter and First Nine Months of 2009

MethylGene Reports Third Quarter 2009 Financial Results

Procter &Amp; Gamble Co. Up 13% Since Added to Galtstock Long Portfolio

Celgene Reports Record Third Quarter 2009 Operating and Financial Results

Pronova BioPharma Receives 2009 Frost &Amp; Sullivan Award for Excellence in Financial &Amp; Risk Management

Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma

85% Profitable Trades Keep Galtstock.Com Subscribers Very Happy

Tennis Legend John McEnroe Tells Men to 'Get Serious' About Prostate Cancer

Lawsuit Claims Celgene Corporation Misappropriated the Idea Behind its Multiple Myeloma Treatments

GSK Advisory: Warehouse Theft

Form 4 PONIARD PHARMACEUTICALS, For: Nov 25 Filed by: JACKSON MICHAEL K (10K)

Form 4 EXELIXIS INC For: Sep 01 Filed by: Lamb Peter (10K)

Form 4 PONIARD PHARMACEUTICALS, For: Nov 15 Filed by: JACKSON MICHAEL K (10K)

Form 4 STEINMETZ MICHAEL For: Nov 05 (10K)

Form 4 SIMON NICHOLAS J III For: Nov 05 (10K)

Form 4 MPM BIOVENTURES III QP For: Nov 05 (10K)

Form 4 Heller Frances K For: Nov 02 (10K)

Form 4 CELGENE CORP /DE/ For: Oct 27 Filed by: Burton Graham (10K)

Form 4 GRYSKA DAVID W For: Oct 13 (10K)

Form 4 Burton Graham For: Oct 13 (10K)